551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study

BACKGROUND: Growing evidence supports the use of remdesivir and tocilizumab for the treatment of hospitalized patients with severe COVID-19. The purpose of this study was to evaluate the use of remdesivir and tocilizumab for the treatment of severe COVID-19 in a community hospital setting. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Nava, Guillermo, Egoryan, Goar, Trelles-Garcia, Daniela Patricia, Yanez-Bello, Maria Adriana, Zhang, Qishuo, Chung, Chul Won, Ozcekirdek, Emre E, Ozen, Ece, Poudel, Bidhya, Cohen, Heather, Friedman, Harvey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644042/
http://dx.doi.org/10.1093/ofid/ofab466.750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644042/
http://dx.doi.org/10.1093/ofid/ofab466.750

Ejemplares similares